However, how the various cells residing in the TME of germline BRCA1/BRCA2-deficient breast tumors that are equally impaired by the same germline mutation contribute to the pathogenesis of the hereditary breast cancer has not been consistently addressed. This evidence concerns the gene BRCA2 and breast cancer.